Gilead Sciences Inc. has appointed Keeley Wettan as Executive Vice President, General Counsel, Legal & Compliance effective ...

Chitose Laboratory Corp., a provider of advanced cell line development services, and Fujifilm Biosciences Inc., a leader in ...

Topical, transdermal, and long-acting injectables are moving fast, and expectations for purity, performance, and regulatory ...

Halo Pharma is expanding manufacturing capacity at its Whippany, NJ, facility with the addition of a Gerteis Macro-Pactor.

Exdensur is the first and only ultra-long-acting biologic for patients with severe asthma with an eosinophilic phenotype.

Lubrizol offers an array of pharmaceutical excipients for oral, topical and injectable applications. The company’s portfolio ...

Galux has signed a research agreement with Boehringer Ingelheim to jointly explore the application of AI in precision protein ...

Harbour BioMed, a global biopharmaceutical company, has announced a multi-year, global strategic collaboration and license ...

MEDI&GENE, a biopharmaceutical company, has entered into a Catalyze agreement with Eli Lilly and Company to advance a ...

Lindus Health and Quotient Sciences have partnered to enable enhanced patient recruitment for Phase I-IIa clinical studies ...

NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production, and commercialization of ...

ADEL Inc., a biopharma company, has entered into an exclusive worldwide license agreement with Sanofi for the development and ...